Aug. 19 at 9:16 AM
$UVIX $LITE $CCXI $ALAB UVIX provides leveraged volatility exposure, Lumentum benefits from optical and AI-networking demand, ChemoCentryx-related CCXI remains tied to biotechnology development, and Astera Labs benefits from AI connectivity infrastructure. I'm watching volatility, AI capex, clinical catalysts, and data-center demand.